Axentra Corp Limited vs BHEL

A side-by-side comparison of Axentra Corp Limited (AXENTRA) and BHEL (BHEL) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, BHEL leads AXENTRA vs BHEL on 8 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation13
  • Profitability22
  • Growth10
  • Size & financial health13
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

BHEL takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

0.00
P/E ratio
52.07
18.11
P/B ratio
5.61
0.00%
Dividend yield
0.33%
₹0.00
EPS
₹4.60

Profitability

Even

How efficiently each company turns capital and sales into profit. Higher is better.

-4.03%
Return on equity
6.12%
-4.71%
Return on capital
8.43%
40.00%
EBITDA margin
6.93%
13.33%
Net margin
4.74%

Growth

AXENTRA takes 1/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

—
Revenue CAGR (3Y) even
13.08%
370.27%
Profit CAGR (3Y)
49.66%

Size & financial health

BHEL takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹564 Cr
Market cap
₹1.50L Cr
₹0 Cr
Revenue
₹33,782 Cr
₹0 Cr
Net profit
₹1,600 Cr
0.03
Debt / equity
0.31
Axentra Corp Limited
  • + ["Company is almost debt free."]
  • − ["Stock is trading at 18.05 times its book value"]
BHEL
  • + ["Company has been maintaining a healthy dividend payout of 30.5%"]
  • − ["Stock is trading at 5.74 times its book value", "Company has a low return on equity of 3.2% over last 3 years."]
Axentra Corp Limited full analysis BHEL full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

AXENTRA vs BHEL: Share Price, Valuation & Growth Compared | DocStoX